Hemotune
Developer of a tunable magnetic nanoparticle platform and integrated extracorporeal magnetic separation system. The company focuses on selective removal or capture of biomolecules from complex fluids for clinical therapies (e.g., antibody depletion for gene therapy, multi-target blood purification for sepsis) and for high-value bioprocessing. Activities include nanoparticle design, device engineering, preclinical GLP testing, and quality systems aligned with medical device standards.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Application-specific magnetic nanoparticle sorbents
Tunable magnetic particles with functionalized surfaces and binding agents customized to capture or deplete defined molecular targets in blood or process streams.
Integrated extracorporeal magnetic separation system and single-use kits
A clinical device platform that combines a control unit, magnetic capture hardware, and sterile single-use tubing assemblies and sorbent cartridges to perform precision blood purification treatments.
HemoSystem
A complete solution bringing together HemoBeads, the HemoDevice, and the single-use HemoKit for implementing medical treatments.
HemoSorbent
The HemoSorbent is an application-specific magnetic sorbent containing customized HemoBeads tailored to selectively deplete harmful compounds.
HemoBeads
Nanoengineered magnetic particles designed for exceptional selectivity and efficiency with a modular structure that allows customization for specific targets.
HemoKit
The HemoKit is a single-use sterile tubing set designed for safety and simplicity, forming the extracorporeal circuit.
Application-specific magnetic nanoparticle sorbents
Tunable magnetic particles with functionalized surfaces and binding agents customized to capture or deplete defined molecular targets in blood or process streams.
Integrated extracorporeal magnetic separation system and single-use kits
A clinical device platform that combines a control unit, magnetic capture hardware, and sterile single-use tubing assemblies and sorbent cartridges to perform precision blood purification treatments.
HemoSystem
A complete solution bringing together HemoBeads, the HemoDevice, and the single-use HemoKit for implementing medical treatments.
HemoSorbent
The HemoSorbent is an application-specific magnetic sorbent containing customized HemoBeads tailored to selectively deplete harmful compounds.
HemoBeads
Nanoengineered magnetic particles designed for exceptional selectivity and efficiency with a modular structure that allows customization for specific targets.
HemoKit
The HemoKit is a single-use sterile tubing set designed for safety and simplicity, forming the extracorporeal circuit.
Services
Evaluation of target binding and capture conditions in relevant matrices to determine technical feasibility for magnetic separation applications.
Define integration points with chromatography, filtration, and analytics; develop workflows for adding a magnetic separation step into existing trains.
Support for preclinical GLP studies, device validation, and preparation for clinical trials including safety, biodistribution and treatment-simulation studies.
Evaluation of target binding and capture conditions in relevant matrices to determine technical feasibility for magnetic separation applications.
Define integration points with chromatography, filtration, and analytics; develop workflows for adding a magnetic separation step into existing trains.
Support for preclinical GLP studies, device validation, and preparation for clinical trials including safety, biodistribution and treatment-simulation studies.
Expertise Areas
- Magnetic nanoparticle engineering and surface functionalization
- Extracorporeal blood purification and device development
- Preclinical GLP studies and biocompatibility assessment
- Medical device quality systems and ISO 13485 compliance
Key Technologies
- Magnetic nanoparticle sorbents
- Affinity-functionalized particle surfaces
- Extracorporeal magnetic capture systems
- Single-use sterile tubing assemblies
News & Updates
Publication of a peer-reviewed GLP preclinical study assessing safety, biodistribution, and removal efficiency of a complete magnetic separation-based blood purification system (including ≥99.9% particle removal in simulations).
Participation as a founding member in a European Sepsis Alliance working group focused on sepsis in cancer patients and related research and advocacy.
ISO 13485:2016 certification covering design, development, production and distribution of medical devices for blood purification and coated colloidal nanoparticles; scope extension announced.
Raised CHF 14 million in Series B2 funding to advance clinical trials with the extracorporeal magnetic separation system.
Announcement of appointment to President of the Board of Directors.
Publication of a peer-reviewed GLP preclinical study assessing safety, biodistribution, and removal efficiency of a complete magnetic separation-based blood purification system (including ≥99.9% particle removal in simulations).
Participation as a founding member in a European Sepsis Alliance working group focused on sepsis in cancer patients and related research and advocacy.
ISO 13485:2016 certification covering design, development, production and distribution of medical devices for blood purification and coated colloidal nanoparticles; scope extension announced.
Raised CHF 14 million in Series B2 funding to advance clinical trials with the extracorporeal magnetic separation system.
Announcement of appointment to President of the Board of Directors.